PROGESTERONE-RECEPTOR-POSITIVE BREAST CANCER

Clinical trials for PROGESTERONE-RECEPTOR-POSITIVE BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new PROGESTERONE-RECEPTOR-POSITIVE BREAST CANCER trials appear

Sign up with your email to follow new studies for PROGESTERONE-RECEPTOR-POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1 Terminated 2

First patients to try groundbreaking oral cancer pill

Disease control Recruiting now

This is the first study in people to test a new oral drug called NKT3964. It aims to see if the drug is safe and can help control advanced cancers that have spread and stopped responding to standard treatments. The study will enroll adults with specific advanced solid tumors, inc…

Matched conditions: PROGESTERONE-RECEPTOR-POSITIVE BREAST CANCER

Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

PROGESTERONE-RECEPTOR-POSITIVE BREAST CANCER

Get alerted when new PROGESTERONE-RECEPTOR-POSITIVE BREAST CANCER trials appear

First patients to try groundbreaking oral cancer pill